Anders Gabrielsen

Chief Tech/Sci/R&D Officer at SUZHOU RIBO LIFE SCIENCE CO., LTD.

60 year

Health Technology

Consumer Services

Profile

Anders Gabrielsen is currently an Independent Director at Novakand Pharma AB since 2018.
Dr. Gabrielsen is an Associate Professor at Karolinska Institutet.
Dr. Gabrielsen is the Chief Medical Officer at Suzhou Ribo Life Science Co., Ltd. starting in 2026.
Formerly, Dr. Gabrielsen was Director-Global Medical Affairs Unit at Novartis Sverige AB from 2016 to 2018.

Anders Gabrielsen active positions

Companies	Position	Start
KANCERA AB	Director/Board Member	30/05/2018
SUZHOU RIBO LIFE SCIENCE CO., LTD.	Chief Tech/Sci/R&D Officer	-
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Anders Gabrielsen

Former positions of Anders Gabrielsen

Companies	Position	End
Novartis Sverige AB Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs	Chief Tech/Sci/R&D Officer	01/05/2018

See the detail of Anders Gabrielsen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anders Gabrielsen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Sverige AB Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs	Health Technology
Kancera AB Kancera AB Pharmaceuticals: MajorHealth Technology Develops drugs against inflammation and cancer	Health Technology
Suzhou Ribo Life Science Co., Ltd. Suzhou Ribo Life Science Co., Ltd. Pharmaceuticals: GenericHealth Technology Develops siRNA therapeutics for liver, cardiovascular, metabolic and renal diseases	Health Technology